IDEXX Laboratories, Inc.
IDXX
Jodie read · what matters now
Revenue increased 14.3% versus the comparable filing period.
The story is only the start. Jodie keeps watching the filing evidence, the companies connected to IDXX, and whether its market group begins moving.
Latest filing assessment · baseline
The latest filing presents a mixed picture
10-Q filed 2026-05-05 against the comparable filing from 2025-05-01.
What improved
- Revenue increased 14.3% versus the comparable filing period.
What weakened
No thresholded deterioration was identified.
Filing receipts
“The increase in gross profit was primarily due to higher revenue as well as a 190 basis point increase in the gross profit margin.”
“Sales and marketing expense increased primarily due to higher personnel-related costs and higher commercial activities.”
“Sales and marketing expense increased primarily due to commercial investments and higher personnel-related costs.”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Who this business touches
The relationships behind IDXX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Filing peers
Companies whose filings use similar operating language.
You can see the shape of the network here. Pro opens the original filing receipts, and alerts when connected names begin moving. See Pro →
What is moving around it
Live connections
IDXX is currently a Follower in the organic co-movement group Healthcare Investment Firms. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.
Theme membership history
No durable theme membership has been observed for this name yet.